Cite
Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients.
MLA
Sims, Jonathan T., et al. “Longitudinal Assessment of Systemic Steroid Therapy on Hyperinflammatory Endothelial Biomarker Profiles and Serology Responses of COVID-19 Patients.” Journal of Translational Medicine, vol. 20, no. 1, Sept. 2022, pp. 1–3. EBSCOhost, https://doi.org/10.1186/s12967-022-03583-5.
APA
Sims, J. T., Chang, C.-Y., Poorbaugh, J., Daniels, M., Beasley, S. L., Zhang, L., Rodgers, G. H., Lena, F., Lacerenza, L. G., Sposato, B., Dupont, A., Susen, S., Casalini, G., Corbellino, M., Stebbing, J., & Krishnan, V. (2022). Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients. Journal of Translational Medicine, 20(1), 1–3. https://doi.org/10.1186/s12967-022-03583-5
Chicago
Sims, Jonathan T., Ching-Yun Chang, Josh Poorbaugh, Montanea Daniels, Stephanie L. Beasley, Lin Zhang, George H. Rodgers, et al. 2022. “Longitudinal Assessment of Systemic Steroid Therapy on Hyperinflammatory Endothelial Biomarker Profiles and Serology Responses of COVID-19 Patients.” Journal of Translational Medicine 20 (1): 1–3. doi:10.1186/s12967-022-03583-5.